REV-201

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameREV-201
Drug Alias Namerepurposed cannabinoid-based therapeutics (Revive Therapeutics)REV-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid modulators
TargetsUpdating
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevive Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRevive Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A